{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:50:37Z","timestamp":1790812237808,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jacl.2018.09.007","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T17:19:00Z","timestamp":1537291140000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence"],"prefix":"10.1016","volume":"13","author":[{"given":"Vadzim","family":"Chyzhyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kozmic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Hudgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Starc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley Deleigh","family":"Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Diffenderfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.09.007_bib1","first-page":"1165","article-title":"Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndrome","volume":"Vol 1","author":"Brunzell","year":"1989"},{"key":"10.1016\/j.jacl.2018.09.007_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM196702022760507","article-title":"Fat transport in lipoproteins \u2013 an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.09.007_bib3","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1016\/S0021-9258(18)63614-2","article-title":"Studies of the proteins in human plasma very low density lipoproteins","volume":"244","author":"Brown","year":"1969","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.09.007_bib4","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/S0021-9258(18)62574-8","article-title":"Further characterization of apolipoproteins from the human plasma very low density lipoproteins","volume":"245","author":"Brown","year":"1970","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.09.007_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-291X(70)90468-7","article-title":"A specific apoprotein activator for lipoprotein lipase","volume":"41","author":"LaRosa","year":"1970","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacl.2018.09.007_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0022-2275(20)36886-3","article-title":"Selective measurement of two different triglyceride lipase activities in rat postheparin plasma","volume":"14","author":"Krauss","year":"1973","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.09.007_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/01.RES.33.4.403","article-title":"Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins","volume":"33","author":"Krauss","year":"1973","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2018.09.007_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-87-5-526","article-title":"Primary type V hyperlipoproteinemia. A descriptive study in 32 families","volume":"87","author":"Greenberg","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2018.09.007_bib9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM197806082982301","article-title":"Hypertriglyceridemia associated with deficiency of apolipoprotein C-II","volume":"298","author":"Breckenridge","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.09.007_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia--current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2018.09.007_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2018.09.007_bib12","series-title":"Endotext [Internet]","first-page":"1","article-title":"The measurement of lipids, lipoproteins, apolipoproteins, fatty acids, and sterols, and next generation sequencing for the diagnosis and treatment of lipid disorders","author":"Schaefer","year":"2016"},{"key":"10.1016\/j.jacl.2018.09.007_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.09.007_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1373\/clinchem.2009.137489","article-title":"Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study","volume":"56","author":"Ai","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2018.09.007_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2010.02.041","article-title":"Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study","volume":"213","author":"Otokozawa","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2018.09.007_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jacl.2017.01.014","article-title":"Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa population study and the Framingham Offspring Study","volume":"11","author":"Ikezaki","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.09.007_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2018.09.007_bib18","first-page":"1837","article-title":"Total parenteral nutrition in a pregnant patient with acute pancreatitis and lipoprotein lipase deficiency","volume":"32","author":"Contreras-Bolivar","year":"2015","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.jacl.2018.09.007_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jca.20192","article-title":"Management of familial hypertriglyceridemia during pregnancy with plasma exchange","volume":"24","author":"Sivakumaran","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jacl.2018.09.007_bib20","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1210\/jc.2012-1250","article-title":"Severe hypertriglyceridemia in pregnancy","volume":"97","author":"Goldberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.09.007_bib21","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1016\/S0021-9258(19)39449-9","article-title":"Missense mutation (Gly\/Glu188) of human lipoprotein lipase imparting functional deficiency","volume":"265","author":"Emi","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.09.007_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(96)00005-8","article-title":"Molecular pathobiology of the human lipoprotein lipase gene","volume":"70","author":"Murthy","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacl.2018.09.007_bib23","doi-asserted-by":"crossref","first-page":"E1675","DOI":"10.1210\/jc.2011-1444","article-title":"GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia","volume":"96","author":"Charri\u00e8re","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.09.007_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/jamainternmed.2016.6875","article-title":"Nonfasting mild to moderate hypertriglyceridemia and risk of acute pancreatitis","volume":"176","author":"Pedersen","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacl.2018.09.007_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2018.09.007_bib26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jacl.2018.04.009","article-title":"The burden of familial chylomicronemia syndrome: results from the global IN-FOCUS study","volume":"12","author":"Davidson","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.09.007_bib27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacl.2018.04.010","article-title":"Familial chylomicronemia syndrome: bringing to life dietary recommendations throughout the life span","volume":"12","author":"Williams","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.09.007_bib28","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.09.007_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamainternmed.2013.13309","article-title":"Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide","volume":"174","author":"Sacks","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacl.2018.09.007_bib30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MOL.0000000000000231","article-title":"Novel therapeutics in hypertriglyceridemia","volume":"26","author":"Gryn","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2018.09.007_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.09.007_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1210\/jcem-57-2-262","article-title":"The effect of estrogen administration on plasma lipoprotein metabolism in premenopausal females","volume":"57","author":"Schaefer","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.09.007_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/lipd.12011","article-title":"Differential effects of estrogen and progestin on apolipoprotein B100 and B48 kinetics in postmenopausal women","volume":"53","author":"Lamon-Fava","year":"2018","journal-title":"Lipids"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418304057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418304057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T21:23:01Z","timestamp":1662067381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418304057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1933287418304057"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.09.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}